Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Becton Dickinson and Company (BDX)

Healthcare Medical Instruments & Supplies
165.60 $
+0.1% vs. previous close
Closing price · As of: 31. Jul 2026

Becton Dickinson and Company (BDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 50,832 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet BDX
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
53,017 52,780 52,274 54,157 55,582 57,286 54,665 54,467 54,902 55,325 54,841 50,832
8,588 8,676 8,156 10,340 12,207 10,468 8,659 8,666 8,997 9,255 9,189 8,012
923 1,416 1,180 2,348 4,459 1,856 711 667 735 851 1,024 813
931 1,424 1,182 3,175 5,310 2,301 728 683 757 859 1,035 816
2,414 2,534 2,267 2,559 2,596 3,033 2,638 3,029 2,943 2,994 2,508 2,205
3,588 3,273 3,304 3,229 3,255 3,843 3,860 3,723 3,949 3,894 4,085 3,357
6,474 6,557 – – – 6,821 6,602 6,646 6,818 6,997 6,972 –
24,584 24,522 24,597 24,566 24,546 26,465 26,329 26,444 26,597 33,023 26,620 25,955
11,313 10,947 10,614 10,260 9,911 10,917 10,489 10,133 9,788 2,994 9,025 8,348
27,079 26,983 26,941 28,509 29,713 31,397 29,461 29,226 29,429 29,936 29,559 26,699
6,878 6,640 7,540 7,327 6,605 8,956 7,664 7,691 8,160 8,313 8,761 8,507
1,856 1,141 2,016 2,016 1,192 2,312 1,318 1,604 1,810 1,560 2,623 2,573
5,021 1,641 5,524 4,871 4,964 1,896 6,347 6,087 6,350 1,974 6,138 –
14,926 14,738 14,094 15,995 18,131 17,940 17,440 17,666 17,531 17,621 16,916 14,706
25,938 25,797 25,333 25,648 25,869 25,889 25,204 25,241 25,473 25,390 25,282 24,133
15,691 15,535 15,540 15,802 16,015 16,139 16,141 16,150 16,426 16,622 16,704 17,391
288 293 291 290 290 291 290 289 289 287 285 281

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?